A committed academic professional with a Ph.D. in Molecular Biology & Biotechnology and more than 10 years of experience in translational research, specializing in biologics characterization, method validation, and regulatory compliance. Experienced in teaching and leading cross-functional teams. Passionate about undergraduate education, I am seeking the position of Lecturer at RCSI, where I can apply my research expertise and teaching background to contribute to the development of innovative medical curricula, deliver high-quality education, and enhance student engagement through dynamic, creative teaching methods.
Publications in International Peer Reviewed Journals.
1. Gogoi, D., Yu, H., Casey, M., Baird, R., Yusuf, A., Forde, L., ... & Reeves, E. P. (2024). Monocyte NLRP3 inflammasome and interleukin-1β activation modulated by alpha-1 antitrypsin therapy in deficient individuals. BMJ Thorax.
2. Forde, L., Gogoi, D., Baird, R., McCarthy, C., Keane, M. P., Reeves, E. P., & McGrath, E. E. (2024). Does ATP via purinergic receptor signalling fuel pulmonary fibrosis?. Journal of Innate Immunity, 1-14.
3. Baird, R., Yusuf, A., Forde, L., Pohl, K., Kavanagh, K., Fitzpatrick, F., ... Gogoi, D., & Reeves, E. P. (2024). The vacuolar anti-Pseudomonal activity of neutrophil primary granule peptidyl-arginine deiminase enzymes. Frontiers in Immunology, 15, 1452393.
4. Gogoi, D., Chattopadhyay, P., Dolui, S. K., Khan, M. R., & Mukherjee, A. K. (2024). Studies on in vivo antithrombotic activity of quercetin, a natural flavonoid isolated from a traditional medicinal plant, African eggplant (Solanum indicum). Journal of Ethnopharmacology, 335, 118686.
5. Lacey, N., Teo, J. Y., Baird, R., Forde, L., Hawkins, P., McEnery, T., ... Gogoi, D., & Reeves, E. P. (2024). Augmentation Therapy Decreases Platelet-Neutrophil Aggregates in Alpha-1 Antitrypsin Deficiency. American Journal of Respiratory Cell and Molecular Biology, 70(6), 524-527.
6. Das, M. J., Banerjee, D., Banerjee, A., Muchahary, S., Sinha, A., Gogoi, D., ... & Deka, S. C. (2024). Safety and antidiabetic activity of Lagenaria siceraria (Molina) Standl. juice in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology, 319, 117111.
7. McEnery, T., White, M. M., Gogoi, D., Coleman, O., Bergin, D., Jundi, B., ... & Reeves, E. P. (2022). Alpha-1 antitrypsin therapy modifies neutrophil adhesion in patients with obstructive lung disease. American Journal of Respiratory Cell and Molecular Biology, 67(1), 76-88.
8. Caird, R., Williamson, M., Yusuf, A., Gogoi, D., Casey, M., McElvaney, N. G., & Reeves, E. P. (2022). Targeting of glycosaminoglycans in genetic and inflammatory airway disease. International Journal of Molecular Sciences, 23(12), 6400.
9. O’Brien, M. E., Murray, G., Gogoi, D., Yusuf, A., McCarthy, C., Wormald, M. R., ... & Reeves, E. P. (2022). A review of alpha-1 antitrypsin binding partners for immune regulation and potential therapeutic application. International Journal of Molecular Sciences, 23(5), 2441.
10. Fee, L. T., Gogoi, D., O’Brien, M. E., McHugh, E., Casey, M., Gough, C., ... & Reeves, E. P. (2021). C3d elicits neutrophil degranulation and decreases endothelial cell migration, with implications for patients with alpha-1 antitrypsin deficiency. Biomedicines, 9(12), 1925.
11. Gogoi, D., Jha, S., Chattopadhyay, P., & Mukherjee, A. K. (2020). A simple, cost‐effective, and rapid separation process for the isolation of anticoagulant active fraction from the fruit extract of Momordica charantia: Characterization of bioactive components and anticoagulant mechanism of active fraction in a mouse model. Journal of Separation Science, 43(20), 3902-3912.
12. Gogoi, D., Ramani, S., Bhartari, S., Chattopadhyay, P., & Mukherjee, A. K. (2019). Characterization of active anticoagulant fraction and a fibrin (ogen) olytic serine protease from leaves of Clerodendrum colebrookianum, a traditional ethno-medicinal plant used to reduce hypertension. Journal of ethnopharmacology, 243, 112099.
13. Gogoi, D., Pal, A., Chattopadhyay, P., Paul, S., Deka, R. C., & Mukherjee, A. K. (2018). First report of plant-derived β-sitosterol with antithrombotic, in vivo anticoagulant, and thrombus-preventing activities in a mouse model. Journal of natural products, 81(11), 2521-2530.
14. Bora, B., Gogoi, D., Tripathy, D., Kurkalang, S., Ramani, S., Chatterjee, A., & Mukherjee, A. K. (2018). The N-terminal-truncated recombinant fibrin (ogen) olytic serine protease improves its functional property, demonstrates in vivo anticoagulant and plasma defibrinogenation activity as well as pre-clinical safety in rodent model. International journal of biological macromolecules, 111, 462-474.
15. Gogoi, D., Arora, N., Kalita, B., Sarma, R., Islam, T., Ghosh, S. S., ... & Mukherjee, A. K. (2018). Anticoagulant mechanism, pharmacological activity, and assessment of preclinical safety of a novel fibrin (ogen) olytic serine protease from leaves of Leucas indica. Scientific reports, 8(1), 6210.
16. Gogoi, D., Bhagowati, P., Gogoi, P., Bordoloi, N. K., Rafay, A., Dolui, S. K., & Mukherjee, A. K. (2016). Structural and physico-chemical characterization of a dirhamnolipid biosurfactant purified from Pseudomonas aeruginosa: application of crude biosurfactant in enhanced oil recovery. RSC advances, 6(74), 70669-70681.
17. Dutta, S., Gogoi, D., & Mukherjee, A. K. (2015). Anticoagulant mechanism and platelet deaggregation property of a non-cytotoxic, acidic phospholipase A2 purified from Indian cobra (Naja naja) venom: inhibition of anticoagulant activity by low molecular weight heparin. Biochimie, 110, 93-106.
18. Majumdar, S., Sarmah, B., Gogoi, D., Banerjee, S., Ghosh, S. S., Banerjee, S., ... & Mukherjee, A. K. (2014). Characterization, mechanism of anticoagulant action, and assessment of therapeutic potential of a fibrinolytic serine protease (Brevithrombolase) purified from Brevibacillus brevis strain FF02B. Biochimie, 103, 50-60.
Book Chapter:
Under Communication
Publication in International/National Conferences
1. Gogoi, D. Faisal., A., Baird, R., Forde, L., Ahmed, S., Niu, M., Reeves, E. (2025). The impact of MZB1 protein expression in immune and hepatic cells in AATD. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/ajrccm.2025.211.Abstracts.A3479
2. Gogoi, D., Casey, M., Bolger, C., Alghamdi, S., Acquilini, P., D’Costa, L., ... & Reeves, E. (2023). CFTR Modulator Therapy Rescues CFTR and Lowers P2X7R-induced Inflammasome Activation of Airway Epithelial Cells. ERJ Open Research 9 (suppl 12)
3. Baird, R., Gogoi, D., Yusuf, A., Murray, G., Murphy, M., Casey, M., & Reeves, E. (2023). Peptidyl-arginine deiminases–neutrophil derived proteins as anti-Pseudomonas aeruginosa agents in patients with cystic fibrosis. ERJ Open Research 9 (suppl 10)
4. Gogoi, D., Casey, M., Yusuf, A., Gabillard-Lefort, C., Gunaratnam, C., McElvaney, N. G., & Reeves, E. P. (2022, December). Decreased anti-neutrophil cytoplasmic autoantibodies (ANCA) against bactericidal/permeability-increasing (BPI) post CFTR modulator therapy. in Irish Journal Of Medical Science (vol. 191, pp. s160-s161).
5. Yusuf, A., Casey, M., Gogoi, D., Gabillard-Lefort, C., Gunaratnam, C., McElvaney, N. G., & Reeves, E. P. (2022, December). The CFTR modulator combination elexacaftor/tezacaftor/ivacaftor restores CFTR protein expression in circulating neutrophils of patients with cystic fibrosis. in Irish Journal Of Medical Science (Vol. 191, pp. S160-S160).
6. Gogoi, D.,Casey, M., Yusuf, A., Fraughen, D., Herron, M., Alhaddah, L., ... & Reeves, E. P. (2022, December). Inhibition of C3d signalling downregulates NLRP3 inflammasome activation and IL-1 beta production in monocytes of individuals with alpha-1 antitrypsin deficiency. in Irish Journal Of Medical Science (Vol. 191, pp. S173-S173).
7. Baird, R. D., Gogoi, D., Yusuf, A., Casey, M., Murray, G., Murphy, M., & Reeves, E. P. (2022, December). Investigating peptidyl-arginine deiminases as novel antimicrobial agents against bacterial pathogens of patients with cystic fibrosis. in Irish Journal Of Medical Science (Vol. 191, pp. S160-S160).
8. Yusuf, A., Gogoi, D., Gabillard-Lefort, C., Gunaratnam, C., McElvaney, N. G., Casey, M., & Reeves, E. P. (2022, December). Circulating soluble P2X7 receptor as a novel indicator of resolution of inflammation in patients with cystic fibrosis. in Irish Journal Of Medical Science (Vol. 191, pp. S184-S185).
9. Gogoi, D.,Fee, L. T., O’Brien, M. E., Murphy, M., Hopkins, A., Carroll, T. P., ... & Reeves, E. P. (2022). C3d Triggers Neutrophil Degranulation And Decreases Endothelial Cell Migration, with Implications for Patients with Alpha-1 Antitrypsin Deficiency. in B21. Basic, Clinical, And Translational Copd Studies: The Ongoing Hunt For Underlying Mechanisms And Therapeutic Targets (pp. A2415-A2415). American Thoracic Society.
Granted Patent
Research Funding
US Alpha 1 Foundation, May 2025, $150000
Principal Investigator
RCSI, 3 May 2024, €150000
Co- Applicant
Alpha-1 Foundation (US), 19 May 2023 - 30 September 2024, €75000
Co- Applicant
RCSI, 23 Jan 2023, €150000
Co-Applicant
RCSI, 5 Jan 2023, € 2000
Strategic Partnership Pfizer Healthcare Ireland, 19 July 2022- 30 September 2023, € 20000
Co-Applicant
RCSI, 16 May 2022, € 2000
BIRAC-DBT India, 16 October 2016- 15 October 2018
BIRAC/IKP0333/BIG-08/16 to AKM
1. Prof. Emer Reeves
Department of Anesthesia & Critical Care
Royal College of Surgeons in Ireland
Email id: emerreeves@rcsi.ie
2. Dr. Bhaskarjyoti Gogoi
Department of Biotechnology
Royal Global University, Assam
Email Id: gogoi.bhaskar2608@gmail.com